High-Affinity Peptide-Drug Conjugate Ligands for the TRIM24 PHD and Bromodomain.
Platt MA. et al, (2025), Chemistry, 31
Immunopeptidomics Workflow for Isolation and LC-MS/MS Analysis of MHC Class I-Bound Peptides Under Hypoxic Conditions.
Estephan H. et al, (2025), Bio Protoc, 15
A guide to reactive oxygen species in tumour hypoxia: measurement and therapeutic implications.
Hacker L. et al, (2025), Mol Oncol, 19, 3003 - 3022
Reversible Enzymatic Switching of the Oxidation State of a EuIII/II Complex Controls Relaxivity.
Sarson ET. et al, (2025), J Am Chem Soc, 147, 38992 - 38997
Identification of a photoredox-active Pt(IV) complex that induces light-mediated cell death.
Marsh JW. et al, (2025), Chem Sci, 16, 19187 - 19191
Indolequinone-Based Hypoxia-Activated Proteolysis Targeting Chimeras Selectively Degrade BRD4 in Hypoxic Cancer Cells.
Serafini M. et al, (2025), J Am Chem Soc, 147, 36352 - 36364
Silencing of SOD1 sensitises ATRX-deficient cells to camptothecin treatment through increased activity of the alternative lengthening of telomeres pathway.
Mattis N. et al, (2025), Hum Mol Genet, 34, 1638 - 1647
Hypoxia-activated fluorescent probes as markers of oxygen levels in plant cells and tissues.
Perri M. et al, (2025), New Phytol, 247, 2998 - 3009
UPR-induced intracellular C5aR1 promotes adaptation to the hypoxic tumour microenvironment.
Suwa T. et al, (2025), Cell Death Dis, 16
Binuclear Lanthanide Complexes as Magnetic Resonance and Optical Imaging Probes for Redox Sensing.
Simms CH. et al, (2025), Chemistry, 31
LnDOTA Releasing Probes for Luminescence and Magnetic Resonance Imaging.
Foster CA. et al, (2025), Inorg Chem, 64, 6640 - 6647
Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers.
Goncalves T. et al, (2025), Nucleic Acids Res, 53
Elevated reactive oxygen species can drive the alternative lengthening of telomeres pathway in ATRX-null cancers.
Goncalves T. et al, (2025), Nucleic Acids Res, 53
Hypoxia promotes tumor immune evasion by suppressing MHC-I expression and antigen presentation.
Estephan H. et al, (2025), EMBO J, 44, 903 - 922
Characterisation of Tropomyosin 3, a novel hypoxia induced gene, in Triple Negative Breast Cancer
Booker G. et al, (2025), BREAST, 80
ZBTB7A forms a heterodimer with ZBTB2 and inhibits ZBTB2 homodimerization required for full activation of HIF-1.
Kambe G. et al, (2024), Biochem Biophys Res Commun, 733
The activity of therapeutic molecular cluster Ag5 is dependent on oxygen level and HIF-1 mediated signalling.
Twigger SA. et al, (2024), Redox Biol, 76